Updated Interim Clinical Considerations—Optimal Interval Between 1st and 2nd mRNA Vaccine Series
EU now advises 3-week interval between Pfizer vaccine doses | Reuters
Singapore OKs Covid vaccine for children, outlines inoculation plan
Coronavirus vaccination: the most important questions and answers
Evaluation of COVID-19 vaccination strategies with a delayed second dose | medRxiv
Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses | Nature Immunology
Vaccine Locations | Will County Health Department
1) Why should children and adolescents aged 6 months to 17 years receive COVID-19 vaccine? In the early stage of the COVID-19
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
FDA Authorizes 3rd Dose of Pfizer Vaccine for Immunocompromised Kids — Children's Cancer Cause
2021-07-07-grafik-impfstoffe.png
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England | Nature Communications
Is there a minimum and maximum time interval between COVID-19 vaccine doses? | COVID-19 Info Vaccines
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study - The Lancet
Testing fractional doses of COVID-19 vaccines | PNAS
Know Your Vaccines (Vaccine Matrix: Current Evidence) | Department of Health website
Introduction of shorter interval between vaccine doses | Department of Health
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study - The Lancet Oncology
What is the evidence for extending the SARS-CoV-2 (COVID-19) vaccine dosing schedule? | British Columbia Medical Journal
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine - ScienceDirect
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine - ScienceDirect
Evaluation of COVID-19 vaccination strategies with a delayed second dose | PLOS Biology
Chart: 28 Days Later: The Pfizer/BioNTech Vaccination Process | Statista
What is the recommended interval between doses? - MOH FAQ - AskGov
